Ropes & Gray advised Fulcrum Therapeutics on the transaction. Fulcrum Therapeutics, Inc. (Fulcrum) (Nasdaq: FULC) announced it has entered into a collaboration and license agreement with...
Fulcrum Therapeutics’ Collaboration and License Agreement with Sanofi
Fulcrum Therapeutics’ $125 Million Public Offering of Common Stock
Goodwin Procter advised Fulcrum Therapeutics on the deal. Fulcrum Therapeutics, Inc. (Nasdaq: FULC) announced its underwritten public offering of 9,615,384 shares of its common stock at...